Udall Project 2 Aim 2A&C
RecruitingNCT05656586Phase: Not specifiedStarted 2023-01-01
Summary
This protocol will leverage the novel (on-label, FDA-approved) local field potential measuring capability of the Medtronic Percept™ PC or RC DBS system to study the effects of globus pallidus internus
Eligibility
Sex
ALL
Min Age
None
Max Age
None
Locations
University of MinnesotaMinneapolis, Minnesota, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05656586